+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase



Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase



Veterinary and Comparative Oncology 14(4): 371-383



Feline oral squamous cell carcinoma (SCC) has very poor prognosis. Here, a retrospective pilot study was conducted on 20 feline oral SCC patients who underwent stereotactic radiation therapy (SRT), to evaluate: (1) the value of putative tumour initiating cell (TIC) markers of human head and neck SCC (CD44, Bmi-1); (2) telomere length (TL) specifically in putative TICs; and (3) tumour relative telomerase activity (TA). Significant inverse correlations were found between treatment outcomes and Bmi-1 expression, supporting the predictive value of Bmi-1 as a negative prognostic indicator. While TL exhibited a wide range of variability, particularly in very short fractions, many tumours possessed high levels of TA, which correlated with high levels of Bmi-1, Ki67 and EGFR. Taken together, our results imply that Bmi-1 and telomerase may represent novel therapeutic targets in feline oral SCC, as their inhibition - in combination with SRT - would be expected to have beneficial treatment outcome.

(PDF emailed within 0-6 h: $19.90)

Accession: 055098411

Download citation: RISBibTeXText

PMID: 25212092

DOI: 10.1111/vco.12117


Related references

Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. Veterinary Journal 193(1): 46-52, 2012

Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications. Cancer Metastasis Reviews 35(3): 457-474, 2017

Prognostic significance of VEGF-C in predicting micrometastasis and isolated tumour cells in N0 oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 46(3): 194-200, 2016

Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma. International Journal of Molecular Sciences 20(6), 2019

Feline Oral Squamous Cell Carcinoma: Clinical Manifestations and Literature Review. Journal of Veterinary Dentistry 32(1): 30-40, 2015

Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: Value of computed tomography-determined tumour parameters. Radiotherapy & Oncology 50(1): 39-46, 1999

Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 40(8): 636-642, 2012

CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo. Microvascular Research 112: 101-108, 2017

Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system. Histopathology 70(7): 1125-1137, 2017

Squamous cell carcinoma of the oral cavity and circulating tumour cells. World Journal of Clinical Oncology 5(2): 114-124, 2014

Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck. Radiotherapy & Oncology 50(1): 47-55, 1999

Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma. Annals of Surgical Oncology 16(7): 2058-2064, 2009

Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma. Histopathology 67(5): 730-739, 2016

Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma. Histopathology 65(1): 24-34, 2015

The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma. Oral Diseases 3(2): 82-85, 1997